| BÜCHLER, Tomáš, Marta KREJČÍ, A. SVOBODNÍK, Zdeněk ADAM, J. MINAŘÍK, J. BAČOVSKÝ, V. ŠČUDLA, Jiří MAYER, Jiří VORLÍČEK and Roman HÁJEK. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. The hematology journal. England: Nature Publishing Group, 2005, vol. 5, No 7, p. 559-564. ISSN 1466-4860. |
Other formats:
BibTeX
LaTeX
RIS
@article{837912,
author = {Büchler, Tomáš and Krejčí, Marta and Svobodník, A. and Adam, Zdeněk and Minařík, J. and Bačovský, J. and Ščudla, V. and Mayer, Jiří and Vorlíček, Jiří and Hájek, Roman},
article_location = {England},
article_number = {7},
keywords = {multiple myeloma; hypertension; angiotensin-1-converting enzyme},
language = {eng},
issn = {1466-4860},
journal = {The hematology journal},
title = {Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.},
volume = {5},
year = {2005}
}
TY - JOUR
ID - 837912
AU - Büchler, Tomáš - Krejčí, Marta - Svobodník, A. - Adam, Zdeněk - Minařík, J. - Bačovský, J. - Ščudla, V. - Mayer, Jiří - Vorlíček, Jiří - Hájek, Roman
PY - 2005
TI - Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.
JF - The hematology journal
VL - 5
IS - 7
SP - 559-564
EP - 559-564
PB - Nature Publishing Group
SN - 14664860
KW - multiple myeloma
KW - hypertension
KW - angiotensin-1-converting enzyme
N2 - In a retrospective study we have sought to determine whether the administration of angiotensin-I-converting enzyme inhibitors (ACEI) influences the outcome of patients with multiple myeloma (MM). Patients with MM who underwent autologous peripheral blood stem cell transplantation (PBSCT) (n=168) were studied. Patients taking ACEI alone or in combination with other antihypertensive agents during the hospital admission for PBSCT were allocated to the ACEI group (n=25; 15%). In conclusion, according to our findings, ACEI administered during PBSCT have adverse effect on survival of patients with MM.
ER -
BÜCHLER, Tomáš, Marta KREJČÍ, A. SVOBODNÍK, Zdeněk ADAM, J. MINAŘÍK, J. BAČOVSKÝ, V. ŠČUDLA, Jiří MAYER, Jiří VORLÍČEK and Roman HÁJEK. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. \textit{The hematology journal}. England: Nature Publishing Group, 2005, vol.~5, No~7, p.~559-564. ISSN~1466-4860.
|
